4//SEC Filing
Blackman Samuel C. 4
Accession 0001415889-24-027234
CIK 0001845337other
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 4:34 PM ET
Size
18.0 KB
Accession
0001415889-24-027234
Insider Transaction Report
Form 4
Blackman Samuel C.
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2024-11-15+6,062→ 1,066,221 total - Exercise/Conversion
Common Stock
2024-11-15+1,437→ 1,060,159 total - Sale
Common Stock
2024-11-18$13.21/sh−2,206$29,142→ 1,064,015 total - Exercise/Conversion
Restricted Stock Unit (RSU)
2024-11-15−1,187→ 4,756 total→ Common Stock (1,187 underlying) - Exercise/Conversion
Restricted Stock Unit (RSU)
2024-11-15−6,062→ 72,752 total→ Common Stock (6,062 underlying) - Exercise/Conversion
Common Stock
2024-11-15+1,187→ 1,058,722 total - Exercise/Conversion
Restricted Stock Unit (RSU)
2024-11-15−1,437→ 11,504 total→ Common Stock (1,437 underlying)
Holdings
- 1,000,000(indirect: See footnote)
Common Stock
Footnotes (6)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock upon settlement for no consideration.
- [F2]The sale of shares is for the sole purpose of covering the Reporting Person's tax liability with respect to the settlement of RSUs.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold as part of block trades for multiple security holders of the Issuer at prices ranging from $13.02 to $13.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein with regard to the block trade.
- [F4]The Reporting Person is the sole manager, and has shared voting and dispositive power with his wife as members. The Reporting Person continues to report beneficial ownership of all of the Issuer's Common Stock held by the 2021 Blackman Family LLC but disclaims beneficial ownership except to the extent of his and his wife's pecuniary interest therein.
- [F5]The RSUs will vest as to 1/16th of the total award in quarterly installments on February 15, May 15, August 15 and November 15, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
- [F6]RSUs do not expire; they either vest or are canceled prior to the vesting date.
Documents
Issuer
Day One Biopharmaceuticals, Inc.
CIK 0001845337
Entity typeother
Related Parties
1- filerCIK 0001863676
Filing Metadata
- Form type
- 4
- Filed
- Nov 18, 7:00 PM ET
- Accepted
- Nov 19, 4:34 PM ET
- Size
- 18.0 KB